LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | GW843682X | 0.04 | uM | LJP6 | 1 | B18 | 72 | hr | 1389 | 4095 | 5147 | 0.7956 | 0.7721 |
MCF7 | AT-7519 | 0.04 | uM | LJP6 | 2 | K06 | 72 | hr | 1389 | 5687 | 5447 | 1.0439 | 1.0440 |
MCF7 | Tozasertib | 0.04 | uM | LJP5 | 3 | B18 | 72 | hr | 1389 | 1524 | 6038 | 0.2524 | 0.0447 |
MCF7 | AT-7519 | 0.04 | uM | LJP6 | 3 | K06 | 72 | hr | 1389 | 5080 | 5740 | 0.8849 | 0.8841 |
MCF7 | AZD7762 | 0.04 | uM | LJP6 | 1 | L06 | 72 | hr | 1389 | 2020 | 5147 | 0.3925 | 0.2192 |
MCF7 | AZD7762 | 0.04 | uM | LJP6 | 2 | L06 | 72 | hr | 1389 | 2012 | 5447 | 0.3693 | 0.2067 |
MCF7 | AZD7762 | 0.04 | uM | LJP6 | 3 | L06 | 72 | hr | 1389 | 1929 | 5740 | 0.3360 | 0.1740 |
MCF7 | HG-5-113-01 | 0.04 | uM | LJP5 | 1 | B12 | 72 | hr | 1389 | 5066 | 5772 | 0.8776 | 0.8769 |
MCF7 | HG-5-113-01 | 0.04 | uM | LJP5 | 3 | B12 | 72 | hr | 1389 | 5170 | 6038 | 0.8562 | 0.8588 |
MCF7 | CP724714 | 0.04 | uM | LJP5 | 1 | A12 | 72 | hr | 1389 | 5249 | 5772 | 0.9093 | 0.9096 |
MCF7 | HG-5-88-01 | 0.04 | uM | LJP6 | 3 | A24 | 72 | hr | 1389 | 3530 | 5740 | 0.6149 | 0.5771 |
MCF7 | CP724714 | 0.04 | uM | LJP5 | 3 | A12 | 72 | hr | 1389 | 5230 | 6038 | 0.8661 | 0.8689 |
MCF7 | CP466722 | 0.04 | uM | LJP5 | 3 | I12 | 72 | hr | 1389 | 6478 | 6038 | 1.0728 | 1.0674 |
MCF7 | Sorafenib | 0.04 | uM | LJP6 | 3 | B12 | 72 | hr | 1389 | 5350 | 5740 | 0.9320 | 0.9323 |
MCF7 | Alvocidib | 0.04 | uM | LJP6 | 1 | A18 | 72 | hr | 1389 | 1324 | 5147 | 0.2572 | -0.0251 |
MCF7 | Sorafenib | 0.04 | uM | LJP6 | 2 | B12 | 72 | hr | 1389 | 5724 | 5447 | 1.0507 | 1.0508 |
MCF7 | CP466722 | 0.04 | uM | LJP5 | 1 | I12 | 72 | hr | 1389 | 6117 | 5772 | 1.0597 | 1.0572 |
MCF7 | Sorafenib | 0.04 | uM | LJP6 | 1 | B12 | 72 | hr | 1389 | 4484 | 5147 | 0.8712 | 0.8592 |
MCF7 | AZD8055 | 0.04 | uM | LJP6 | 3 | A12 | 72 | hr | 1389 | 1466 | 5740 | 0.2554 | 0.0267 |
MCF7 | Alvocidib | 0.04 | uM | LJP6 | 2 | A18 | 72 | hr | 1389 | 1933 | 5447 | 0.3548 | 0.1825 |
MCF7 | JW-7-24-1 | 0.04 | uM | LJP6 | 2 | B24 | 72 | hr | 1389 | 4202 | 5447 | 0.7713 | 0.7532 |
MCF7 | Seliciclib | 0.04 | uM | LJP5 | 1 | J06 | 72 | hr | 1389 | 5915 | 5772 | 1.0247 | 1.0239 |
MCF7 | AZD8055 | 0.04 | uM | LJP6 | 1 | A12 | 72 | hr | 1389 | 1326 | 5147 | 0.2576 | -0.0243 |
MCF7 | NVP-TAE684 | 0.04 | uM | LJP6 | 3 | K18 | 72 | hr | 1389 | 4508 | 5740 | 0.7853 | 0.7773 |
MCF7 | NVP-TAE684 | 0.04 | uM | LJP6 | 2 | K18 | 72 | hr | 1389 | 4569 | 5447 | 0.8387 | 0.8293 |